Laboratory Medicine ›› 2015, Vol. 30 ›› Issue (8): 857-860.DOI: 10.3969/j.issn.1673-8640.2015.08.020

Previous Articles     Next Articles

The progress of anti-carbamylated protein antibody

CHEN Yiqiong, ZHAO Di, LI Zhi.   

  1. Department of Clinical Laboratory, Shanghai Yangpu District Central Hospital, Shanghai 200090, China
  • Received:2014-09-10 Online:2015-08-30 Published:2015-08-28

Abstract:

The key to the treatment of rheumatoid arthritis(RA) is early diagnosis and treatment. It becomes urgent to find sensitive and specific biomarkers for the early diagnosis of RA. In recent years, anti-carbamylated protein (Carp) antibody is attention. Anti-Carp antibody can improve the susceptibility of anti-citrullinated protein antibody (ACPA)-negative RA patients, and the anti-Carp antibody presents in about 30% ACPA-negative RA patients. Like ACPA, anti-Carp antibody is also a biomarker for the early diagnosis of RA. This paper will give a review of the progress.

Key words: Anti-carbamylated protein antibody, Rheumatoid arthritis, Auto-antibody

CLC Number: